tirzepatide oral drops side effects Shed Tirzepatide Oral Sublingual Tablets in

Beginning in 2025 and 2026, several major BCBS affiliates have either dropped or significantly restricted coverage for GLP-1 weight-loss medications due to rising costs

[PMC free article: PMC4441672] [PubMed: 25666208] (23 year old man developed rash [photosensitive], fever and jaundice several months after starting Hydroxycut for weight loss [bilirubin 24.4 mg/dL, ALT 92 U/L, Alk P 91 U/L, INR 1.5] and had a prolonged and complicated course during which the diagnosis of hereditary coproporphyria was made, possibly explaining at least some of the clinical features)

Rare: mild nausea (brief, self-resolving)

Try to exhale slowly as you trigger the pen